Citigroup’s NeuroSense Therapeutics NRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-49,744
Closed -$168K 5271
2022
Q2
$168K Buy
49,744
+49,734
+497,340% +$168K ﹤0.01% 3283
2022
Q1
$0 Buy
+10
New ﹤0.01% 5567